Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum
Primary Purpose
Heart Failure
Status
Unknown status
Phase
Phase 2
Locations
Norway
Study Type
Interventional
Intervention
CRT in heart failure; Right ventricular apex v.s. high posterior septum
CRT in heart failure; Right ventricular apex v.s. high posterior septum
Sponsored by
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring Pacemaker treatment in heart failure, Cardiac resynchronization therapy, DDD pacemakers
Eligibility Criteria
Inclusion Criteria:
CRT:
- LVEF < 35%
- LVEDD > 5.5 cm
- NYHA 3-4
- QRS > 120 ms
- Optimal medical treatment
- Both CRT-pacemakers (CRT-P) and CRT combined with ICD (CRT-D)
Exclusion Criteria:
- Not fulfilling inclusion criteria or not written consensus
Sites / Locations
- Haukeland University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
CRT; RV apical lead placement
CRT; RV high posterior septum
Arm Description
Right ventricular apical lead placement in CRT
High posterior septal lead placement in CRT
Outcomes
Primary Outcome Measures
Echocardiographic reverse remodelling and dyssynchrony
Secondary Outcome Measures
Full Information
NCT ID
NCT01035489
First Posted
December 17, 2009
Last Updated
May 23, 2011
Sponsor
Haukeland University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01035489
Brief Title
Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum
Official Title
Echocardiographic Dyssynchrony in Heart Failure in CRT; Right Ventricular Apex v.s. High Posterior Septum
Study Type
Interventional
2. Study Status
Record Verification Date
May 2011
Overall Recruitment Status
Unknown status
Study Start Date
January 2009 (undefined)
Primary Completion Date
June 2012 (Anticipated)
Study Completion Date
June 2012 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Haukeland University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In heart failure patients we hypothesised that right ventricular high posterior septum is superior to right ventricular apex in CRT and DDD pacemaker. In two separate trials we prospectively randomized the right ventricular lead placement to find evidence of differences in heart failure symptoms (NYHA-class), 6 minute hall walk and echocardiographic measurements of reverse remodelling and dyssynchrony.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
Pacemaker treatment in heart failure, Cardiac resynchronization therapy, DDD pacemakers
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
85 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
CRT; RV apical lead placement
Arm Type
Active Comparator
Arm Description
Right ventricular apical lead placement in CRT
Arm Title
CRT; RV high posterior septum
Arm Type
Active Comparator
Arm Description
High posterior septal lead placement in CRT
Intervention Type
Device
Intervention Name(s)
CRT in heart failure; Right ventricular apex v.s. high posterior septum
Intervention Description
RV lead is randomized to either apex or high posterior septum
Intervention Type
Device
Intervention Name(s)
CRT in heart failure; Right ventricular apex v.s. high posterior septum
Intervention Description
RV lead is randomized to either apex or high posterior septum
Primary Outcome Measure Information:
Title
Echocardiographic reverse remodelling and dyssynchrony
Time Frame
3, 6, 12, 18 and 24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
CRT:
LVEF < 35%
LVEDD > 5.5 cm
NYHA 3-4
QRS > 120 ms
Optimal medical treatment
Both CRT-pacemakers (CRT-P) and CRT combined with ICD (CRT-D)
Exclusion Criteria:
Not fulfilling inclusion criteria or not written consensus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Svein Faerestrand, MD, PhD
Organizational Affiliation
Faerestrand S
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haukeland University Hospital
City
Bergen
ZIP/Postal Code
5021
Country
Norway
12. IPD Sharing Statement
Citations:
PubMed Identifier
22677455
Citation
Kristiansen HM, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging. 2012 Dec;13(12):991-1000. doi: 10.1093/ehjci/jes114. Epub 2012 Jun 7.
Results Reference
derived
PubMed Identifier
22308084
Citation
Kristiansen HM, Hovstad T, Vollan G, Keilegavlen H, Faerestrand S. Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy. Europace. 2012 Jul;14(7):986-93. doi: 10.1093/europace/eur429. Epub 2012 Feb 2.
Results Reference
derived
PubMed Identifier
22286156
Citation
Kristiansen HM, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy. Eur J Heart Fail. 2012 May;14(5):506-16. doi: 10.1093/eurjhf/hfr162. Epub 2012 Jan 26.
Results Reference
derived
Learn more about this trial
Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum
We'll reach out to this number within 24 hrs